10-K Decoder · All companies

Amphastar Pharmaceuticals, Inc.

AMPH · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$720M$732M−1.7%
Operating income$140M$205M−31.7%
Net income$98.1M$160M−38.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$208M$192M+8.2%
Operating income$50.8M$25.3M+101%
Net income$37.8M$17.4M+117%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Amphastar's revenue in FY2025?
$720M in FY2025 (Fiscal year ended Dec 31, 2025), −1.7% vs $732M a year earlier, per its 10-K filed Feb 2026.
Was Amphastar profitable in FY2025?
Yes: net income was $98.1M and operating income $140M in FY2025.
What was Amphastar's revenue in Q3 2026?
$208M (+8.2% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.